Betta Pharmaceuticals (China) Market Value

300558 Stock   52.69  1.11  2.06%   
Betta Pharmaceuticals' market value is the price at which a share of Betta Pharmaceuticals trades on a public exchange. It measures the collective expectations of Betta Pharmaceuticals Co investors about its performance. Betta Pharmaceuticals is trading at 52.69 as of the 28th of November 2024, a 2.06 percent decrease since the beginning of the trading day. The stock's open price was 53.8.
With this module, you can estimate the performance of a buy and hold strategy of Betta Pharmaceuticals Co and determine expected loss or profit from investing in Betta Pharmaceuticals over a given investment horizon. Check out Betta Pharmaceuticals Correlation, Betta Pharmaceuticals Volatility and Betta Pharmaceuticals Alpha and Beta module to complement your research on Betta Pharmaceuticals.
Symbol

Please note, there is a significant difference between Betta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Betta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Betta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Betta Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Betta Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Betta Pharmaceuticals.
0.00
10/29/2024
No Change 0.00  0.0 
In 31 days
11/28/2024
0.00
If you would invest  0.00  in Betta Pharmaceuticals on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Betta Pharmaceuticals Co or generate 0.0% return on investment in Betta Pharmaceuticals over 30 days. Betta Pharmaceuticals is related to or competes with Sinocelltech, Dhc Software, Olympic Circuit, Guangzhou Dongfang, Changchun, Hengli Industrial, and Guangdong Brandmax. Betta Pharmaceuticals is entity of China More

Betta Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Betta Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Betta Pharmaceuticals Co upside and downside potential and time the market with a certain degree of confidence.

Betta Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Betta Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Betta Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Betta Pharmaceuticals historical prices to predict the future Betta Pharmaceuticals' volatility.
Hype
Prediction
LowEstimatedHigh
48.4953.1157.73
Details
Intrinsic
Valuation
LowRealHigh
36.0940.7157.96
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.250.250.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Betta Pharmaceuticals. Your research has to be compared to or analyzed against Betta Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Betta Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Betta Pharmaceuticals.

Betta Pharmaceuticals Backtested Returns

Betta Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Betta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. By analyzing Betta Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please makes use of Betta Pharmaceuticals' Downside Deviation of 3.68, mean deviation of 3.06, and Risk Adjusted Performance of 0.1404 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Betta Pharmaceuticals holds a performance score of 13. The firm shows a Beta (market volatility) of -0.0281, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Betta Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Betta Pharmaceuticals is likely to outperform the market. Please check Betta Pharmaceuticals' total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Betta Pharmaceuticals' price patterns will revert.

Auto-correlation

    
  0.79  

Good predictability

Betta Pharmaceuticals Co has good predictability. Overlapping area represents the amount of predictability between Betta Pharmaceuticals time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Betta Pharmaceuticals price movement. The serial correlation of 0.79 indicates that around 79.0% of current Betta Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.79
Spearman Rank Test0.76
Residual Average0.0
Price Variance6.38

Betta Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Betta Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Betta Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Betta Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Betta Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Betta Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Betta Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Betta Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Betta Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Betta Pharmaceuticals Lagged Returns

When evaluating Betta Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Betta Pharmaceuticals stock have on its future price. Betta Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Betta Pharmaceuticals autocorrelation shows the relationship between Betta Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Betta Pharmaceuticals Co.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Betta Stock

Betta Pharmaceuticals financial ratios help investors to determine whether Betta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Betta with respect to the benefits of owning Betta Pharmaceuticals security.